Kidney transplant patients: which drug better protects your new organ?
Disease control
Ongoing
This study looks at kidney transplant patients who are at least one year post-surgery and currently taking a combination of two immunosuppressants. Researchers want to see if switching to either RaparoBell or Myrept is safer and more effective at preventing organ rejection, graft…
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC